Association for Clinical and Translational Science (ACTS) is pleased to announce the results of their recent elections for the Board of Directors for 2024-2025. The board's role is to govern, establish policy, and make strategic decisions about the organization's future.
The new board assumed office at the close of the Translational Science 2024 meeting on April 5, 2024.
A special acknowledgment to our own GHUCCTS member, Dr. Pascalev, for being elected for another year.
Congratulations to Dr. Pascalev!
The 2024-2025 ACTS Board of Directors:
Board of Directors:
- Allan Brasier, MD - University of Wisconsin-Madison
- Linda B. Bottler, PhD, MPH, FACE - University of Florida
- Joyce (Joy) Balls-Berry, PhD, MPE - Washington University in St. Louis School for Medicine
- Williams W. Stoops, PhD- University of Kentucky
Directors at Large:
- R. Lane Coffee, PhD, MS - University of Central Florida
- Peter Elkin, MD - University of Buffalo
- Felicity T. Enders, PhD - Mayo Clinic
- Laura James, MD - University of Arkansas
- Nita Limdi, PharmD, PhD, MSPH, FAHA - University of Alabama at Birmingham
- Shari Messinger, ME, PhD - University of Miami
- Assya Pascalev, PhD - Howard University
- Doris M. Rubio, PhD - University of Pittsburgh
- Lourdes E. Soto de Laurido, Ed.D, MPHE - University of Puerto Rico
- Heidi Spratt, PhD - University of Texas Medical Branch
- Martin S. Zand, MD, PhD - University of Rochester
Ex-Officio Members:
- Chris Lindsell, PhD - Duke University
- Robert P. Kimberly, MD - University of Alabama at Birmingham